What is Rapport Therapeutics, Inc.'s other income (expense)?

Rapport Therapeutics, Inc. (RAPP) reported other income (expense) of $4.36M in Q1 2026.

How has Rapport Therapeutics, Inc.'s other income (expense) changed year-over-year?

Rapport Therapeutics, Inc.'s other income (expense) increased by 43.1% year-over-year, from $3.05M to $4.36M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Rapport Therapeutics, Inc. RAPP Other Income (Expense)

Other Income (Expense) at other companies

Supernus PharmaceuticalsSUPN

$2.38M-46.2%

Xenon PharmaceuticalsXENE

$7.46M-8.2%

Praxis Precision Medicines, Inc.PRAX

$13.3M+145%

BiohavenBHVN

$168K-65.9%

Septerna, Inc.SEPN

$5M+12.8%

PVL

Palvella TherapeuticsPVLA

-$32K-114%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

CapEx$86.0K-70.4%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s other income (expense)?: Rapport Therapeutics, Inc. (RAPP) reported other income (expense) of $4.36M in Q1 2026.
How has Rapport Therapeutics, Inc.'s other income (expense) changed year-over-year?: Rapport Therapeutics, Inc.'s other income (expense) increased by 43.1% year-over-year, from $3.05M to $4.36M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.